Position in NBIX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$36,236,931
-$5,332,874 QoQ
Shares Held
275,064
-6.2% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $163,728,631 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
458,854 | $54,241,131 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
63,066 | $37,396,876 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
275,064 | $36,236,931 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,286,841 | $21,770,726 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
467,562 | $14,082,967 |
All Filings in NBIX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,236,931 | 275,064 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $41,569,805 | 293,096 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $40,379,605 | 287,645 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $37,524,875 | 298,551 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $36,590,904 | 330,840 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $41,492,178 | 303,972 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $55,679,028 | 483,241 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $64,080,841 | 465,467 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $43,539,137 | 315,684 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $48,737,892 | 369,899 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $42,439,275 | 377,238 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $41,531,228 | 440,416 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $42,226,959 | 417,180 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $32,149,903 | 269,172 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $28,833,997 | 271,481 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $32,258,958 | 330,929 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $28,144,406 | 300,207 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $26,395,290 | 309,913 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,817,911 | 81,513 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $7,930,898 | 81,493 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $58,350 | 600 | Principal | Sole | 2021-04-29 | |
| 2021-03-31 | $15,741,760 | 161,869 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $57,510 | 600 | Principal | Sole | 2021-01-22 | |
| 2020-12-31 | $15,515,143 | 161,869 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $15,028,077 | 156,282 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $19,066,404 | 156,282 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $16,164,597 | 186,766 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||